Company Filing History:
2 out of 96 
2 out of 872 
Years Active: 2017-2018
Title: Celebrating the Innovations of Deug-Nam Kwon
Introduction
Deug-Nam Kwon is a renowned inventor based in Seoul, South Korea. With a focus on genetic engineering and biotechnology, he has made significant contributions to the field through his patented inventions. His expertise specializes in developing gene-targeting vectors and methods aimed at advancing medical research.
Latest Patents
Kwon holds two notable patents that illustrate his innovative work. The first patent relates to an interleukin-2 receptor gamma (IL2RG) gene-targeting vector and describes a method for producing an immune cell-deficient transgenic cloned miniature pig. This invention has crucial applications in understanding immune system deficiencies and developing potential therapies. The second patent involves a recombination activating gene 2 (Rag-2) gene targeting vector aimed at producing SCID-like miniature pigs using TALEN-mediated gene targeting. Both patents emphasize Kwon's commitment to improving genetic research and its application in medical science.
Career Highlights
Throughout his career, Deug-Nam Kwon has held positions that align with his passion for research. He has worked with the Konkuk University Industrial Cooperation Corporation, where he expanded his knowledge and expertise in biotechnology. Additionally, he collaborated with The Curators of the University of Missouri, contributing to significant advancements in genetic research.
Collaborations
Kwon’s innovative efforts have been complemented by collaborations with esteemed colleagues, including Jin-Hoi Kim and Kiho Lee. These partnerships have fostered a dynamic research environment, leading to breakthroughs in genetic engineering and cloning techniques.
Conclusion
The work of Deug-Nam Kwon showcases the potential of innovation in biotechnology. His patents reflect a deep commitment to advancing medical science and understanding genetic disorders. As he continues his research and collaboration with others, Kwon remains an influential figure in the landscape of genetic engineering.